Opa Vajragupta
254 Phayathai Rd
Bangkok, 10330, Thailand
Bangkok, 10330, Thailand
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 61 publications
CXCR4-targeted PET imaging of glioblastoma using [68Ga]Ga-TD-01: from pharmacokinetics and dosimetry to theranostic potential.
Journal: EJNMMI radiopharmacy and chemistry
Published: March 02, 2026
Synthesis and preclinical evaluation of 89Zr-DFO-atezolizumab for immuno-PET imaging in colorectal cancer.
Journal: Bioorganic & medicinal chemistry letters
Published: February 12, 2026
Dual COX-2 and EGFR inhibition by pyrazole-ar-turmerone hybrids suppresses colorectal cancer cell proliferation.
Journal: RSC medicinal chemistry
Published: October 10, 2025
Dual-responsive chitosan/alginate magnetic nanoparticles for sequential chemo-photothermal therapy of glioblastoma.
Journal: International journal of biological macromolecules
Published: July 08, 2025
3‑(4-Hydroxyphenyl-1,2,3-Triazol-1-yl)Quinuclidine, a Selective α7 Nicotinic Acetylcholine Receptor Agonist, Attenuates Inflammatory Pain with a Favorable Central Nervous System Safety Profile in Mice.
Journal: ACS pharmacology & translational science
Published: June 14, 2025
Aloifol I Derived from Dendrobium senile Attenuates Sickness Behaviors in Mice via Regulating Peripheral and Central Immune Responses.
Journal: ACS pharmacology & translational science
Published: January 08, 2025
Synthesis, Cytotoxicity, and Mechanistic Evaluation of Tetrahydrocurcumin-Amino Acid Conjugates as LAT1-Targeting Anticancer Agents in C6 Glioma Cells.
Journal: International journal of molecular sciences
Published: September 12, 2024
Radiosynthesis and preclinical evaluation of a 68Ga-labeled tetrahydroisoquinoline-based ligand for PET imaging of C-X-C chemokine receptor type 4 in an animal model of glioblastoma.
Journal: EJNMMI radiopharmacy and chemistry
Published: June 07, 2024
A promising strategy of surface-modified nanoparticles targeting CXCR4 for precision cancer therapy.
A promising strategy of surface-modified nanoparticles targeting CXCR4 for precision cancer therapy.
Journal: Journal of drug targeting
Published: April 18, 2024
Evaluation of (S)-T1 and (S)-T2 ligands targeting α3β4 nAChR as potential nicotine addiction pharmacotherapy.
Journal: Psychopharmacology
Published: December 04, 2023
Enhancing Physicochemical Properties and Biocompatibility of Hollow Porous Iron Oxide Nanoparticles through Polymer-Based Surface Modifications.
Journal: ACS applied bio materials
Published: November 13, 2023
Last Updated: 09/26/2026